| Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign I Poschke, D Mougiakakos, J Hansson, GV Masucci, R Kiessling Cancer research 70 (11), 4335-4345, 2010 | 498 | 2010 |
| A vaccine targeting mutant IDH1 in newly diagnosed glioma M Platten, L Bunse, A Wick, T Bunse, L Le Cornet, I Harting, F Sahm, ... Nature 592 (7854), 463-468, 2021 | 354 | 2021 |
| Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells M Carlsten, H Norell, YT Bryceson, I Poschke, K Schedvins, ... The Journal of Immunology 183 (8), 4921-4930, 2009 | 316 | 2009 |
| Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A Kruschinski, A Moosmann, I Poschke, H Norell, M Chmielewski, ... Proceedings of the National Academy of Sciences 105 (45), 17481-17486, 2008 | 239 | 2008 |
| On the armament and appearances of human myeloid-derived suppressor cells I Poschke, R Kiessling Clinical immunology 144 (3), 250-268, 2012 | 226 | 2012 |
| Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer N Hartmann, NA Giese, T Giese, I Poschke, R Offringa, J Werner, ... Clinical cancer research 20 (13), 3422-3433, 2014 | 220 | 2014 |
| Camouflage and sabotage: tumor escape from the immune system I Poschke, D Mougiakakos, R Kiessling Cancer Immunology, Immunotherapy 60, 1161-1171, 2011 | 214 | 2011 |
| Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms Y Mao, I Poschke, E Wennerberg, Y Pico de Coaña, S Egyhazi Brage, ... Cancer research 73 (13), 3877-3887, 2013 | 197 | 2013 |
| Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines I Poschke, Y Mao, L Adamson, F Salazar-Onfray, G Masucci, R Kiessling Cancer Immunology, Immunotherapy 61, 827-838, 2012 | 155 | 2012 |
| Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma YP de Coana, M Wolodarski, I Poschke, Y Yoshimoto, Y Yang, M Nyström, ... Oncotarget 8 (13), 21539, 2017 | 146 | 2017 |
| Immunosuppressive CD14+ HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation D Mougiakakos, R Jitschin, L Von Bahr, I Poschke, R Gary, B Sundberg, ... Leukemia 27 (2), 377-388, 2013 | 146 | 2013 |
| Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production YP de Coaña, I Poschke, G Gentilcore, Y Mao, M Nyström, J Hansson, ... Cancer immunology research 1 (3), 158-162, 2013 | 142 | 2013 |
| Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial H Norell, I Poschke, J Charo, WZ Wei, C Erskine, MP Piechocki, ... Journal of translational medicine 8, 1-11, 2010 | 140 | 2010 |
| The CD16− CD56bright NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56dim subset H Harlin, M Hanson, CC Johansson, D Sakurai, I Poschke, H Norell, ... The Journal of Immunology 179 (7), 4513-4519, 2007 | 111 | 2007 |
| Pico de Coana Y, Egyhazi Brage S, Schultz I, et al. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms Y Mao, I Poschke, E Wennerberg Cancer Res 73 (13), 3877-87, 2013 | 109* | 2013 |
| Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma I Poschke, M Faryna, F Bergmann, M Flossdorf, C Lauenstein, J Hermes, ... Oncoimmunology 5 (12), e1240859, 2016 | 102 | 2016 |
| Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer M Miyan, J Schmidt-Mende, R Kiessling, I Poschke, J De Boniface Journal of translational medicine 14, 1-11, 2016 | 94 | 2016 |
| Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes I Poschke, Y Mao, R Kiessling, J de Boniface Journal of translational medicine 11, 1-9, 2013 | 90 | 2013 |
| A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma I Poschke, T Lövgren, L Adamson, M Nyström, E Andersson, J Hansson, ... Cancer immunology, immunotherapy 63, 1061-1071, 2014 | 85 | 2014 |
| Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients J de Boniface, Y Mao, J Schmidt-Mende, R Kiessling, I Poschke Oncoimmunology 1 (8), 1305-1312, 2012 | 84 | 2012 |
